C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/36 (2006.01) A61K 38/48 (2006.01) C12N 5/10 (2006.01) C12N 9/64 (2006.01) C12N 15/57 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2103546
The catalytic active site of Factor VII is modified to produce a compound which effectively interrupts the blood coagula- tion cascade. The modifications render Factor VIIa substantially unable to activate plasma Factors X or IX. Pharmaceutical com- positions of the modified Factor VII are used to treat a variety of coagulation-related disorders.
Berkner Kathleen L.
Petersen Lars C.
Gowling Lafleur Henderson Llp
Novo Nordisk A/s
Novo Nordisk Health Care Ag
LandOfFree
Modified factor vii does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified factor vii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified factor vii will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2080028